A company insider recently sold 5,980 shares of Fate Therapeutics Inc [FATE]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Fate Therapeutics Inc revealed its insider Bressi Jerome Charles unloaded Company’s shares for reported $9269.0 on Jan
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Fate Therapeutics Inc revealed its insider Bressi Jerome Charles unloaded Company’s shares for reported $9269.0 on Jan
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Fate Therapeutics Inc’s recently made public that its insider Bressi Jerome Charles unloaded Company’s shares for reported $9269.0 on Jan
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Fate Therapeutics Inc’s recently made public that its Director Redmile Group, LLC acquired Company’s shares for reported $0.67 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.